Tag Archives: Celgene

A Director at Celgene (NASDAQ: CELG) is Buying Shares

Today, a Director at Celgene (CELG – Research Report), Ernest Mario, bought shares of CELG for $180K. Following this transaction Ernest Mario’s holding in the company was increased by 617.28% to a total of $5.46 million. Following Ernest Mario’s last

Celgene (CELG) Gets a Buy Rating from Cantor Fitzgerald

Cantor Fitzgerald analyst Alethia Young reiterated a Buy rating on Celgene (CELG – Research Report) yesterday and set a price target of $100. The company’s shares closed yesterday at $88.46. Young observed: “. We reiterate our Overweight rating and $100

Celgene (CELG) Gets a Hold Rating from Wells Fargo

Wells Fargo analyst Jim Birchenough maintained a Hold rating on Celgene (CELG – Research Report) today. The company’s shares opened today at $87.86. According to TipRanks.com, Birchenough is a 5-star analyst with an average return of 19.9% and a 46.8%

Cantor Fitzgerald Sticks to Their Buy Rating for Celgene (CELG)

Cantor Fitzgerald analyst Alethia Young maintained a Buy rating on Celgene (CELG – Research Report) today and set a price target of $100. The company’s shares closed yesterday at $66.64, close to its 52-week low of $58.59. Young said: “We

Celgene (CELG) Gets a Hold Rating from Morgan Stanley

In a report released today, Matthew Harrison from Morgan Stanley maintained a Hold rating on Celgene (CELG – Research Report), with a price target of $88. The company’s shares closed yesterday at $66.63, close to its 52-week low of $65.76.

Analysts Are Bullish on These Healthcare Stocks: Celgene (CELG), Global Blood Therapeutics (GBT)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Celgene (CELG – Research Report), Global Blood Therapeutics (GBT – Research Report) and RedHill Biopharma (RDHL – Research Report) with bullish sentiments.